Douglas Tsao
Stock Analyst at H.C. Wainwright
(4.86)
# 380
Out of 5,060 analysts
1164
Total ratings
49.3%
Success rate
20.2%
Average return
Main Sectors:
Stocks Rated by Douglas Tsao
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRON Disc Medicine | Maintained: Buy | $120 | $56.84 | +111.12% | 43 | Oct 19, 2026 | |
| PRAX Praxis Precision Medicines | Reiterated: Buy | $1,201 | $241.76 | +396.77% | 59 | Oct 15, 2026 | |
| RZLT Rezolute | Reiterated: Buy | $10 | $3.58 | +179.33% | 50 | Oct 15, 2026 | |
| PCRX Pacira BioSciences | Downgraded: Hold | $38 → $37 | $36.34 | +0.44% | 31 | Oct 9, 2026 | |
| ARGX argenx SE | Reiterated: Buy | $1,202 | $819.14 | +46.74% | 70 | Oct 8, 2026 | |
| IMVT Immunovant | Reiterated: Buy | $41 | $26.73 | +53.39% | 47 | Sep 23, 2026 | |
| RAPP Rapport Therapeutics | Reiterated: Buy | $66 | $27.57 | +139.39% | 14 | Sep 23, 2026 | |
| ALKS Alkermes | Reiterated: Hold | $43 | $41.22 | +4.32% | 61 | Sep 21, 2026 | |
| CABA Cabaletta Bio | Reiterated: Buy | $16 | $1.41 | +1,034.75% | 52 | Sep 21, 2026 | |
| CHRS Coherus Oncology | Reiterated: Buy | $7 | $0.99 | +607.07% | 79 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $0.7246 | +1,556.09% | 42 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $74 | $33.49 | +120.96% | 18 | Sep 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $10.78 | -7.24% | 24 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $41 → $47 | $33.53 | +40.17% | 48 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $167 → $170 | $128.75 | +32.04% | 80 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $7.10 | +83.10% | 57 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.4738 | +1,377.42% | 26 | Aug 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $360 → $1.2 | $0.232 | +417.24% | 10 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $28.84 | +17.89% | 20 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 | $2.35 | +197.87% | 44 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $19.03 | +15.61% | 31 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $0.5 → $1.6 | $0.4882 | +227.73% | 48 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | kr 103.00 | kr 35.90 | +186.91% | 52 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.39 | +403.60% | 13 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $125 → $5 | $0.0005 | n/a | 26 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $3 | $0.000001 | n/a | 13 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $9.82 | n/a | 4 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.90 | n/a | 19 | Nov 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €19.00 → €11.00 | €2.31 | n/a | 7 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $31 → $33 | $38.81 | n/a | 2 | Jul 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $93 → $80 | $16.63 | n/a | 8 | Jun 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $41.22 | $8.92 | n/a | 17 | Jun 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $19.18 | n/a | 2 | May 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $71 → $77 | $79.38 | n/a | 6 | Feb 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $108 → $120 | $170.18 | n/a | 12 | Oct 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $120 | $266.90 | n/a | 3 | Oct 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $121.84 | n/a | 3 | Jun 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $47 → $50 | $18.66 | n/a | 6 | May 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $210.23 | n/a | 7 | Jan 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $300.15 | n/a | 5 | Nov 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $14 → $2 | $10.35 | n/a | 5 | Nov 16, 2016 |
Disc Medicine
Oct 19, 2026
Maintained: Buy
Price Target: $120
Current: $56.84
Upside: +111.12%
Praxis Precision Medicines
Oct 15, 2026
Reiterated: Buy
Price Target: $1,201
Current: $241.76
Upside: +396.77%
Rezolute
Oct 15, 2026
Reiterated: Buy
Price Target: $10
Current: $3.58
Upside: +179.33%
Pacira BioSciences
Oct 9, 2026
Downgraded: Hold
Price Target: $38 → $37
Current: $36.34
Upside: +0.44%
argenx SE
Oct 8, 2026
Reiterated: Buy
Price Target: $1,202
Current: $819.14
Upside: +46.74%
Immunovant
Sep 23, 2026
Reiterated: Buy
Price Target: $41
Current: $26.73
Upside: +53.39%
Rapport Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: $66
Current: $27.57
Upside: +139.39%
Alkermes
Sep 21, 2026
Reiterated: Hold
Price Target: $43
Current: $41.22
Upside: +4.32%
Cabaletta Bio
Sep 21, 2026
Reiterated: Buy
Price Target: $16
Current: $1.41
Upside: +1,034.75%
Coherus Oncology
Sep 21, 2026
Reiterated: Buy
Price Target: $7
Current: $0.99
Upside: +607.07%
Sep 21, 2026
Reiterated: Buy
Price Target: $12
Current: $0.7246
Upside: +1,556.09%
Sep 18, 2026
Reiterated: Buy
Price Target: $74
Current: $33.49
Upside: +120.96%
Sep 10, 2026
Reiterated: Hold
Price Target: $10
Current: $10.78
Upside: -7.24%
Sep 9, 2026
Rated: Buy
Price Target: $41 → $47
Current: $33.53
Upside: +40.17%
Sep 1, 2026
Rated: Buy
Price Target: $167 → $170
Current: $128.75
Upside: +32.04%
Aug 25, 2026
Reiterated: Buy
Price Target: $13
Current: $7.10
Upside: +83.10%
Aug 24, 2026
Reiterated: Buy
Price Target: $7
Current: $0.4738
Upside: +1,377.42%
Aug 14, 2026
Reiterated: Buy
Price Target: $360 → $1.2
Current: $0.232
Upside: +417.24%
Aug 10, 2026
Reiterated: Buy
Price Target: $34
Current: $28.84
Upside: +17.89%
Aug 10, 2026
Reiterated: Hold
Price Target: $7
Current: $2.35
Upside: +197.87%
Aug 7, 2026
Reiterated: Buy
Price Target: $22
Current: $19.03
Upside: +15.61%
Jul 28, 2026
Rated: Hold
Price Target: $0.5 → $1.6
Current: $0.4882
Upside: +227.73%
Jul 24, 2026
Reiterated: Buy
Price Target: kr 103.00
Current: kr 35.90
Upside: +186.91%
Nov 6, 2025
Reiterated: Buy
Price Target: $7
Current: $1.39
Upside: +403.60%
Nov 14, 2024
Downgraded: Hold
Price Target: $125 → $5
Current: $0.0005
Upside: n/a
Aug 21, 2023
Reiterated: Buy
Price Target: $4 → $3
Current: $0.000001
Upside: n/a
Mar 8, 2023
Reiterated: Hold
Price Target: $6
Current: $9.82
Upside: n/a
Nov 30, 2022
Rated: Hold
Price Target: n/a
Current: $1.90
Upside: n/a
Nov 1, 2022
Reiterated: Buy
Price Target: €19.00 → €11.00
Current: €2.31
Upside: n/a
Jul 3, 2018
Reiterated: Sell
Price Target: $31 → $33
Current: $38.81
Upside: n/a
Jun 6, 2018
Downgraded: Hold
Price Target: $93 → $80
Current: $16.63
Upside: n/a
Jun 6, 2018
Upgraded: Buy
Price Target: $41.22
Current: $8.92
Upside: n/a
May 1, 2018
Initiated Coverage: Buy
Price Target: $27
Current: $19.18
Upside: n/a
Feb 16, 2018
Reiterated: Hold
Price Target: $71 → $77
Current: $79.38
Upside: n/a
Oct 27, 2017
Reiterated: Hold
Price Target: $108 → $120
Current: $170.18
Upside: n/a
Oct 27, 2017
Reiterated: Buy
Price Target: $100 → $120
Current: $266.90
Upside: n/a
Jun 22, 2017
Reiterated: Buy
Price Target: $16
Current: $121.84
Upside: n/a
May 22, 2017
Upgraded: Buy
Price Target: $47 → $50
Current: $18.66
Upside: n/a
Jan 18, 2017
Reiterated: Buy
Price Target: $200
Current: $210.23
Upside: n/a
Nov 30, 2016
Upgraded: Hold
Price Target: n/a
Current: $300.15
Upside: n/a
Nov 16, 2016
Reiterated: Sell
Price Target: $14 → $2
Current: $10.35
Upside: n/a